Spots Global Cancer Trial Database for The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Official Title: The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Study ID: NCT05432232
Interventions
Study Description
Brief Summary: The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.
Detailed Description: This trial is a prospective, multi-center, single-arm pilot trial designed to evaluate the effectiveness and safety profile of the HistoSonics Investigational System in treating primary solid renal tumors. Following histotripsy treatment of the solid renal tumor, subjects will undergo imaging ≤36 hours post-index procedure to determine technical success. Additionally, subjects will be followed 180 days (6 months) post-index procedure, with evaluations at the 14-day, 30-day, 90-day, and 180-day time points to establish the efficacy and safety profile of the HistoSonics Investigational System.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Leeds Teaching Hospitals NHS Trust, Leeds, , United Kingdom
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
